vVARDIS Completes IPO on the New York Stock Exchange
On November 13, 2026, vVARDIS Holding AG (vVARDIS), a Zug-based healthcare company in the dental med-tech sector that develops non-invasive, drill-free treatments for dental professionals, listed its Class A ordinary shares on the New York Stock Exchange (NYSE) under the ticker symbol "VVVV". The initial public offering comprised 9,722,223 Class A ordinary shares at a public offering price of USD 18.00 per share, raising gross proceeds of approximately USD 175 million. In connection with the offering, vVARDIS granted the underwriters a 30-day option to purchase up to 1,458,333 additional Class A ordinary shares at the public offering price to cover over-allotments. Goldman Sachs and J.P. Morgan acted as joint bookrunning managers, with William Blair, UBS and Deutsche Bank completing the underwriting syndicate.
Lenz & Staehelin acted as Swiss counsel to the underwriters in this transaction. The team was led by Patrick Schärli (Capital Markets) and included Stephan Erni (Corporate) as well as Kaan Saritas and Laura Wälchli (both Capital Markets).
-
Capital MarketsCorporateCapital MarketsCapital Markets
-